John Montgomery joins the Cymra Life Sciences Board of Directors

Cymra Pharma is pleased to announce John Montgomery as an Executive Director to the Board. John comes with 40yrs of pharmaceutical experience in the US, Europe and Asia.

John was CEO of Alphapharm and Regional Director, Asia Pacific for Merck Generics. Following the Mylan acquisition he was President, Mylan Asia Pacific for 11 years from 1999 to 2010. Alphapharm was and remains, the largest pharmaceutical company in Australia as measured by prescription volume. Since then, John was General Manager of Pfizer Established Products for Australia and NZ and now CEO of Montrose Pharma Pty Ltd. Before Alphapharm, he spent 20 years with Warner Lambert in a variety of roles including Vice President, Portfolio Management North America and Regional President Australia and NZ. He was Chairman of the Generic Medicines Industry Association (GMiA) for 6 years, representing the industry to government.

John Montgomery said “ I am excited about the opportunity for pharmaceutical development in the medical cannabis sector based on the available current medical evidence and am looking forward to helping the team deliver registered cannabis based medicines through its product and clinical development program”

Share on facebook
Share on twitter
Share on linkedin